<DOC>
	<DOCNO>NCT02310204</DOCNO>
	<brief_summary>The primary objective research protocol assess effect structure therapeutic education program quality life patient moderate severe psoriasis</brief_summary>
	<brief_title>Therapeutic Education Program Psoriasis</brief_title>
	<detailed_description>Psoriasis chronic inflammatory skin disease affect 1 3 % French population . Moderate severe psoriasis significant impact quality life . Psoriasis associate increase risk depression , social isolation , unemployment . In addition , recently show patient moderate severe psoriasis increase incidence cardiovascular risk factor hypertension , overweight , hyperlipidemia exposure tobacco alcohol . These so-called comorbidites may negative impact psoriasis management . They also may account reduced life expectancy report patient severe psoriasis . Therapeutic education structure process whose objective help patient acquire maintain competency require live chronic disease . Therapeutic education important process integrate therapeutic strategy . It take account co-morbidities , social psychological context priority need define patient .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Moderate severe psoriasis define patient receive systemic psoriasis treatment include methotrexate , cyclosporine , PUVA , retinoids biological agent significant impact quality life define Skindex &gt; 18 Patients palmoplantar erythrodermic psoriasis may include classified moderate severe accord described definition Patients able give inform consent , Patients able follow program , Patients without social security affiliation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>